statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Longeveron shares are trading higher Monday afternoon. The company announced it submitted paperwork for a share offering.
read more...

Why Longeveron (LGVN) Stock Exploded Higher Today

Gagnants
L'action Etao International Co (NASDAQ:ETAO) a grimp lundi de 104,93% 5,11 dollars lors de la session ordinaire.
L'action Longeveron (NASDAQ:LGVN) a augment de 57,73% 3,47...

12 titres de soins de sant  en mouvement lors de la session du 08/04/2024

Titoli in rialzo
Il titolo Etao International Co (NASDAQ:ETAO) ha avuto un aumento dell'111,47% a 5,27 dollari durante la sessione regolare di luned .
Le azioni di Longeveron (NASDAQ:LGVN) hanno...

12 titoli sanitari in movimento, sessione regolare del 08/04/2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Longeveron Inc trading halted, news pending

Longeveron Inc. (NASDAQ:LGVN  Free Report) shares are going to reverse split on the morning of Wednesday, March 27th. The 1-10 reverse split was announced on Wednesday, March 27th. The number...

Longeveron (NASDAQ:LGVN) Shares Set to Reverse Split on Wednesday, March 27th

Longeveron announces 1-for-10 reverse split of common stock

MIAMI, March 19, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ( Longeveron or Company ), a clinical stage biotechnology company developing regenerative medicines for unmet medical...

Longeveron Announces 1-for-10 Reverse Stock Split

Even though Longeveron Inc. ( NASDAQ:LGVN ) has fallen by 12% over the past week , insiders who sold US$82k worth of...

Longeveron Falls To US$0.51, But Insiders Sold At Lower Price

Company Announces 2024 Strategic Priorities Focused on Advancement of Lomecel-B in Hypoplastic Left Heart Syndrome ELPIS II Phase 2 Trial of Lomecel-B in HLHS Continues Enrollment; Completion of...

Longeveron Reports Year-End 2023 Results and Provides Corporate Update

MIAMI, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical...

Longeveron to Report Year-End 2023 Results and Provide Corporate Update February 27, 2024

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

Volume	395,492.00
52-Wk High	$44.00
52-Wk Low	$1.60

LGVN Longeveron Inc - Ordinary Shares - Class A

About

Feed

News

Earnings

Fundamentals